Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Susan Perlman is a Neurologist in Los Angeles, California. Perlman has been practicing medicine for over 47 years and is rated as an Elite expert by MediFind in the treatment of Hereditary Ataxia. She is also highly rated in 46 other conditions, according to our data. Her top areas of expertise are Acute Cerebellar Ataxia, Spinocerebellar Ataxia, Hereditary Ataxia, and Friedreich Ataxia. She is licensed to treat patients in California. Perlman is currently accepting new patients.
George Wilmot is a Neurologist in Atlanta, Georgia. Wilmot has been practicing medicine for over 30 years and is rated as an Elite expert by MediFind in the treatment of Hereditary Ataxia. He is also highly rated in 40 other conditions, according to our data. His top areas of expertise are Hereditary Ataxia, Spinocerebellar Ataxia, Friedreich Ataxia, and Spinocerebellar Ataxia Type 2. He is licensed to treat patients in Georgia. Wilmot is currently accepting new patients.
Massimo Pandolfo practices in Brussels, Belgium. Pandolfo is rated as an Elite expert by MediFind in the treatment of Hereditary Ataxia. He is also highly rated in 22 other conditions, according to our data. His top areas of expertise are Friedreich Ataxia, Hereditary Ataxia, Spinocerebellar Ataxia, and Acute Cerebellar Ataxia.
Summary: This research investigates how cognitive-affective aspects evolve during the course of SCA3/MJD. Due to COVID-19 pandemics, this study protocol was adapted for online-only consultations. Evaluations happening after March 2020 have been done by videocall with patients, and no neurological evaluation was thus performed on these patients. A scale on Activities of Daily Living was added to the online ...
Summary: The aim of this study is to determine the clinical spectrum and natural progression of Spastic Ataxias (SPAX) and related disorders in a prospective multicenter natural history study, identify digital, imaging and molecular biomarkers that can assist in diagnosis and therapy development and study the genetic etiology and molecular mechanisms of these diseases.